Summit Therapeutics (SMMT) Q1 2025 Earnings

24FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.08
-0.07
-0.06
-0.05

Details

Expected EPS
-0.081811
Actual EPS
-0.08
Surprise EPS
0
Surprise Percent
+2.21%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.08 per share for Q1 2025.

0 Comments

Share your thoughts